Literature DB >> 33478075

Global Trends of Latent Prostate Cancer in Autopsy Studies.

Takahiro Kimura1, Shun Sato2, Hiroyuki Takahashi2, Shin Egawa1.   

Abstract

The incidence of prostate cancer (PC) has been increasing in Asian countries, where it was previously low. Although the adoption of a Westernized lifestyle is a possible explanation, the incidence is statistically biased due to the increase in prostate-specific antigen (PSA) screening and the accuracy of national cancer registration systems. Studies on latent PC provide less biased information. This review included studies evaluating latent PC in several countries after excluding studies using random or single-section evaluations and those that did not mention section thickness. The findings showed that latent PC prevalence has been stable since 1950 in Western countries, but has increased over time in Asian countries. Latent PC in Asian men has increased in both prevalence and number of high-grade cases. Racial differences between Caucasian and Asian men may explain the tumor location of latent PC. In conclusion, the recent increase in latent PC in Asian men is consistent with an increase in clinical PC. Evidence suggests that this increase is caused not only by the increase in PSA screening, but also by the adoption of a more Westernized lifestyle. Autopsy findings suggest the need to reconsider the definition of clinically insignificant PC.

Entities:  

Keywords:  autopsy; latent cancer; prostate cancer

Year:  2021        PMID: 33478075      PMCID: PMC7835858          DOI: 10.3390/cancers13020359

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  62 in total

1.  Latent carcinoma.

Authors:  L M FRANKS
Journal:  Ann R Coll Surg Engl       Date:  1954-10       Impact factor: 1.891

2.  Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants.

Authors:  L S Cook; M Goldoft; S M Schwartz; N S Weiss
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

3.  Association of nm23 protein levels in human prostates with proliferating cell nuclear antigen expression at autopsy.

Authors:  M Igawa; S Urakami; H Shiina; T Ishibe; T Usui; G W Chodak
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

Review 4.  Temporal trends and racial disparities in global prostate cancer prevalence.

Authors:  Timothy R Rebbeck; Gabriel P Haas
Journal:  Can J Urol       Date:  2014-10       Impact factor: 1.344

5.  The localization of prostatic carcinoma. An autopsy study.

Authors:  I Liavåg
Journal:  Scand J Urol Nephrol       Date:  1968

6.  The clinical features of anterior prostate cancers.

Authors:  Theresa M Koppie; Fernando J Bianco; Kentaro Kuroiwa; Victor E Reuter; Bertrand Guillonneau; James A Eastham; Peter T Scardino
Journal:  BJU Int       Date:  2006-10-09       Impact factor: 5.588

7.  International comparison on ras gene mutations in latent prostate carcinoma.

Authors:  M Watanabe; T Shiraishi; R Yatani; A M Nomura; G N Stemmermann
Journal:  Int J Cancer       Date:  1994-07-15       Impact factor: 7.396

8.  Latent prostatic cancer in a consecutive autopsy series.

Authors:  B Hølund
Journal:  Scand J Urol Nephrol       Date:  1980

9.  Geographic pathology of latent prostatic carcinoma.

Authors:  R Yatani; I Chigusa; K Akazaki; G N Stemmermann; R A Welsh; P Correa
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

10.  Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China.

Authors:  F L Gu; T L Xia; X T Kong
Journal:  Urology       Date:  1994-11       Impact factor: 2.649

View more
  7 in total

1.  Urine Cell-Free MicroRNAs in Localized Prostate Cancer Patients.

Authors:  Yoko Koh; Matias A Bustos; Jamie Moon; Rebecca Gross; Romela Irene Ramos; Suyeon Ryu; Jane Choe; Selena Y Lin; Warren M Allen; David L Krasne; Timothy G Wilson; Dave S B Hoon
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

Review 2.  Can Diet Prevent Urological Cancers? An Update on Carotenoids as Chemopreventive Agents.

Authors:  Tomasz Konecki; Aleksandra Juszczak; Marcin Cichocki
Journal:  Nutrients       Date:  2022-03-25       Impact factor: 5.717

3.  The influence of lncRNAs on the prognosis of prostate cancer based on TCGA database.

Authors:  Hang Huang; Yufan Tang; Xueting Ye; Wei Chen; Hui Xie; Shengye Chen
Journal:  Transl Androl Urol       Date:  2021-03

4.  Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer.

Authors:  Dechao Feng; Qiao Xiong; Facai Zhang; Xu Shi; Hang Xu; Wuran Wei; Jianzhong Ai; Lu Yang
Journal:  Front Immunol       Date:  2022-01-27       Impact factor: 7.561

5.  Urological Cancer Panorama in the Second Year of the COVID-19 Pandemic.

Authors:  Estibaliz López-Fernández; Javier C Angulo; José I López; Claudia Manini
Journal:  Cancers (Basel)       Date:  2022-01-19       Impact factor: 6.639

Review 6.  Functions and mechanisms of N6‑methyladenosine in prostate cancer (Review).

Authors:  Hongyuan Wan; Yanyan Feng; Junjie Wu; Lijie Zhu; Yuanyuan Mi
Journal:  Mol Med Rep       Date:  2022-07-20       Impact factor: 3.423

7.  Essential Elements and Isoflavonoids in the Prevention of Prostate Cancer.

Authors:  Iwona J Stanisławska; Ramona Figat; Anna K Kiss; Barbara Bobrowska-Korczak
Journal:  Nutrients       Date:  2022-03-14       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.